Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — IRIX

Balance Sheet

(in millions USD)

Metric	Q4 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Cash & Equivalents	6.03	4.68	4.60	5.57	6.78	7.24	2.39	3.86	4.11	5.42	7.03	7.98	9.82	11.05	13.92	15.86	17.97	20.62	11.63	25.57
Accounts Receivable	7.61	5.67	6.84	7.13	7.14	6.68	5.95	5.95	6.27	6.53	6.73	6.11	6.42	6.93	6.23	6.16	6.81	7.04	7.29	8.52
Inventory	7.88	9.75	9.32	7.30	8.44	10.14	10.82	10.94	11.12	11.00	9.91	10.12	11.13	11.24	10.61	10.77	10.18	9.09	5.71	8.79
Total Current Assets	25.25	23.96	24.58	24.07	26.87	29.13	23.56	24.34	25.01	27.58	27.45	27.34	30.97	34.70	35.77	38.35	39.44	41.93	25.36	43.91
Property, Plant & Equipment	0.06	0.18	0.14	0.02	0.04	0.08	0.12	0.16	0.21	0.27	0.35	0.52	0.40	0.45	0.46	0.44	0.43	0.36	0.45	0.57
Goodwill	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.40	0.97
Intangible Assets	0.98	0.83	0.90	1.06	1.14	1.22	1.31	1.39	1.48	1.56	1.64	1.73	1.81	1.89	1.98	2.06	2.11	2.16	0.07	2.25
Total Non-current Assets*	3.90	3.30	3.69	4.29	4.72	5.11	5.57	5.82	6.24	6.51	6.99	7.61	5.97	6.28	6.52	6.61	6.20	6.10	2.61	6.64
Total Assets	29.15	27.26	28.27	28.35	31.59	34.24	29.14	30.15	31.25	34.09	34.44	34.95	36.94	40.98	42.29	44.96	45.65	48.02	27.97	50.54
Accounts Payable	5.39	6.65	5.75	4.41	5.31	6.05	6.99	6.20	7.77	7.68	4.50	2.61	4.14	3.55	3.86	4.54	3.81	3.45	1.15	3.21
Short-term Debt	--	--	--	--	--	--	1.70	1.30	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	13.21	13.17	12.83	12.39	13.71	14.95	16.56	15.85	16.15	16.07	12.97	10.35	12.24	13.16	12.45	13.63	12.35	12.59	8.68	12.97
Long-term Debt	--	--	--	--	--	--	1.00	1.40	--	--	--	--	--	--	--	--	--	--	1.25	--
Total Non-current Liabilities*	11.02	10.45	10.71	11.28	11.82	12.44	10.48	11.68	10.86	11.54	11.94	12.54	11.25	11.93	12.61	13.25	13.86	14.11	1.92	12.25
Total Liabilities	24.23	23.62	23.54	23.67	25.53	27.38	27.04	27.53	27.00	27.60	24.91	22.89	23.49	25.10	25.06	26.88	26.21	26.70	10.60	25.22
Retained Earnings	(92.45)	(94.24)	(92.97)	(92.26)	(90.69)	(89.69)	(88.01)	(87.12)	(85.18)	(82.51)	(79.04)	(76.08)	(74.33)	(71.56)	(69.72)	(68.57)	(66.80)	(64.56)	(56.94)	(59.73)
Total Stockholder Equity	4.92	3.64	4.73	4.68	6.06	0.85	2.10	2.62	4.25	6.49	9.52	12.06	13.45	15.88	17.23	18.08	19.43	21.33	17.37	25.32

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q4 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	14.72	12.57	11.80	12.48	13.57	11.90	12.70	11.58	12.63	11.76	12.46	12.85	12.86	13.71	15.20	14.64	13.76	13.39	12.30	13.26
Cost of Revenue	9.25	8.27	7.06	8.47	8.89	6.84	7.11	7.26	7.50	7.30	7.57	7.23	7.49	7.77	8.53	8.18	7.49	7.41	6.72	7.48
Gross Profit	5.48	4.30	4.74	4.01	4.68	5.06	5.59	4.32	5.14	4.46	4.89	5.62	5.36	5.94	6.66	6.46	6.27	5.98	5.58	5.78
Research & Development	0.95	0.94	0.91	0.97	0.87	0.88	1.11	1.30	1.50	1.54	1.69	1.54	1.85	1.75	1.45	1.69	1.92	2.12	0.89	1.79
Selling, General & Admin	1.79	1.84	1.62	1.80	2.22	1.93	2.28	2.25	2.79	2.47	2.40	1.95	2.15	2.25	1.80	2.02	1.90	1.84	1.56	2.24
Total Operating Expenses	5.49	5.33	5.07	5.42	5.62	5.26	6.09	6.19	7.77	7.75	7.97	7.31	8.26	8.28	8.07	8.15	8.43	8.25	5.88	7.94
Operating Income	(0.01)	(1.03)	(0.32)	(1.41)	(0.94)	(0.20)	(0.50)	(1.87)	(2.64)	(3.29)	(3.08)	(1.69)	(2.89)	(2.34)	(1.41)	(1.69)	(2.16)	(2.28)	(0.30)	(2.16)
Pretax Income	(0.16)	(1.20)	(0.47)	(1.57)	(0.97)	(1.67)	(0.84)	(1.92)	(2.66)	(3.43)	(2.90)	(1.75)	(2.76)	(2.08)	(1.13)	(1.75)	(2.22)	(2.37)	(0.17)	(2.16)
Tax Provision	0.02	0.07	0.06	0.00	0.02	0.01	(0.01)	0.02	0.02	0.04	0.06	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.01	0.01
Net Income	(0.18)	(1.27)	(0.52)	(1.57)	(0.99)	(1.69)	(0.83)	(1.93)	(2.68)	(3.46)	(2.96)	(1.75)	(2.77)	(2.09)	(1.15)	(1.77)	(2.24)	(2.39)	(0.18)	(2.16)
Basic EPS	(0.01)	(0.07)	(0.03)	(0.09)	(0.06)	(0.10)	(0.05)	(0.12)	(0.16)	(0.21)	(0.18)	(0.11)	(0.17)	(0.13)	(0.07)	(0.11)	(0.14)	(0.15)	(0.02)	(0.14)
Diluted EPS	(0.01)	(0.07)	(0.03)	(0.09)	(0.06)	(0.10)	(0.05)	(0.12)	(0.16)	(0.21)	(0.18)	(0.11)	(0.17)	(0.13)	(0.07)	(0.11)	(0.14)	(0.15)	(0.02)	(0.14)

← Scroll for more columns →

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Operating Cash Flow	0.17	(1.33)	(1.16)	(0.40)	(1.15)	(1.24)	(3.07)	(1.33)	(1.65)	(0.98)	(1.78)	(1.14)	(2.84)	(1.59)	(2.11)	(2.57)	(3.25)	(0.21)	(0.64)	(1.23)
Capital Expenditures	0.05	0.10	0.01	0.01	0.01	0.01	0.00	0.00	0.00	(0.03)	0.08	0.02	0.04	0.08	0.06	0.12	0.03	0.01	0.05	0.13
Free Cash Flow*	0.12	(1.44)	(1.17)	(0.41)	(1.16)	(1.25)	(3.07)	(1.33)	(1.65)	(0.95)	(1.86)	(1.16)	(2.89)	(1.67)	(2.16)	(2.69)	(3.28)	(0.22)	(0.69)	(1.36)
Investing Cash Flow	(0.05)	(0.10)	(0.01)	(0.01)	(0.01)	(0.01)	-0.00	0.00	-0.00	0.03	(0.08)	(0.02)	(0.04)	(0.08)	(0.06)	(0.12)	(0.03)	(0.01)	(0.05)	(0.05)
Financing Cash Flow	(0.04)	-0.00	(0.03)	(0.01)	6.04	(0.22)	2.82	0.00	0.00	0.05	(0.02)	(0.06)	0.04	0.00	(0.03)	(0.05)	0.01	-0.00	(0.03)	(0.43)

← Scroll for more columns →

* Derived from reported values